Over-Expression of Notch1 As a Biomarker for Invasive Breast Ductal Carcinoma

Over-Expression of Notch1 As a Biomarker for Invasive Breast Ductal Carcinoma Publisher

Paryan M¹ ; Tavakoli R² ; Rad SMAH² ; Feizi N³ ; Kamani F⁴ ; Mostafavi E⁵ ; Mohammadiyeganeh S^{6, 7}

Show Affiliations

1. Department of Research and Development, Production and Research Complex, Pasteur Institute of Iran, Tehran, Iran
2. Department of Molecular Biology and Genetic Engineering, Stem Cell Technology Research Center, Tehran, Iran
3. Laboratory of Influenza Research, Pasteur Institute of Iran, Tehran, Iran
4. Department of Surgery, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5. Department of Epidemiology, Pasteur Institute of Iran, Tehran, Iran
6. Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
7. Department of Biotechnology, School of Advanced Technologies in Medicine, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Velenjak, Shahid Chamran Freeway, Tehran, Iran

Source: 3 Biotech Published:2016

Abstract

Breast cancer is the leading cause of cancer-related death in women worldwide. Invasive ductal carcinoma (IDC) is the most frequent invasive form of breast cancer followed by metastasis. There is no accepted marker for distinguishing this form from other less aggressive forms of breast cancer. Therefore, finding new markers especially molecularly detectable ones are noteworthy. It has been shown that NOTCH1 has been overexpressed in the patients with breast cancer, but no study has investigated the expression of NOTCH1 and its correlation with other molecular and hormonal markers of breast cancer so far. In the current study, 20 breast cancer tissues and 20 matched adjacent normal breast tissue from breast cancer patients were obtained and categorized in two groups: patients with IDC and patient with other types of breast cancer. Gene expression analysis using real-time PCR showed that the NOTCH1 gene was significantly overexpressed in patients with IDC. We also found a slight correlation between NOTCH1 overexpression and p53 accumulation in the cancerous cells confirmed by Immunohistochemistry (IHC). This results showed that it is possible to introduce NOTCH1 expression as a novel biomarker of IDC, alone or preferably accompanied by IHC of p53. We also can design new therapeutic agents targeting NOTCH1 expression for inhibition of metastasis in ductal breast carcinoma. © 2016, The Author(s).

2. Significant Random Signatures Reveals New Biomarker for Breast Cancer, BMC Medical Genomics (2019)

Experts (# of related papers)

Lobat Geranpayeh (1)

Style	Citing Format
MLA	Paryan M, et al.. "Over-Expression of Notch1 As a Biomarker for Invasive Breast Ductal Carcinoma." 3 Biotech, vol. 6, no. 1, 2016, pp. 1-5.
APA	Paryan M, Tavakoli R, Rad SMAH, Feizi N, Kamani F, Mostafavi E, Mohammadiyeganeh S (2016). Over-Expression of Notch1 As a Biomarker for Invasive Breast Ductal Carcinoma. 3 Biotech, 6(1), 1-5.
Chicago	Paryan M, Tavakoli R, Rad SMAH, Feizi N, Kamani F, Mostafavi E, Mohammadiyeganeh S. "Over-Expression of Notch1 As a Biomarker for Invasive Breast Ductal Carcinoma." 3 Biotech 6, no. 1 (2016): 1-5.
Harvard	Paryan M et al. (2016) 'Over-Expression of Notch1 As a Biomarker for Invasive Breast Ductal Carcinoma', 3 Biotech, 6(1), pp. 1-5.
Vancouver	Paryan M, Tavakoli R, Rad SMAH, Feizi N, Kamani F, Mostafavi E, et al.. Over-Expression of Notch1 As a Biomarker for Invasive Breast Ductal Carcinoma. 3 Biotech. 2016;6(1):1-5.
BibTex	@article{ author = {Paryan M and Tavakoli R and Rad SMAH and Feizi N and Kamani F and Mostafavi E and Mohammadiyeganeh S}, title = {Over-Expression of Notch1 As a Biomarker for Invasive Breast Ductal Carcinoma}, journal = {3 Biotech}, volume = {6}, number = {1}, pages = {1-5}, year = {2016} }
RIS	TY - JOUR AU - Paryan M AU - Tavakoli R AU - Rad SMAH AU - Feizi N AU - Kamani F AU - Mostafavi E AU - Mohammadiyeganeh S TI - Over-Expression of Notch1 As a Biomarker for Invasive Breast Ductal Carcinoma JO - 3 Biotech VL - 6 IS - 1 SP - 1 EP - 5 PY - 2016 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract